Literature DB >> 23141584

Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up study.

Giovanni Zuliani1, Mario Luca Morieri, Stefano Volpato, Giovanni B Vigna, Cristina Bosi, Marcello Maggio, Antonio Cherubini, Stefania Bandinelli, Jack M Guralnik, Luigi Ferrucci.   

Abstract

Oxidized LDLs (ox.LDLs) uptake by macrophages inside the arterial wall is a crucial step in atherosclerotic disease, and some studies suggest that high ox.LDLs plasma levels might be associated with cardiovascular disease (CVD). However, whether high ox.LDLs continue to be a CVD risk factors in older persons is unknown. We investigated the clinical correlates of plasma ox.LDLs, and their role in predicting long-term CVD/cardiac mortality in 1025 older community dwelling individuals (mean age: 75.5 ± 7.4 years; females: 55%) from the InCHIANTI study. Kaplan-Meier curves were fitted to explore the relationship between tertiles of ox.LDLs (ox.LDL/LDL-C ratio) and time to CVD/cardiac death. Hazard Ratios (HR) were estimated by Cox regression analysis. At multivariate analysis, ox.LDLs were independently associated with LDL-C, triglycerides, and HDL-C (adjusted r(2): 0.42; P = 0.001). The ox.LDL/LDL-C ratio (the extent of LDLs oxidation) was independently correlated with HDL-C, triglycerides, and beta-carotene (adjusted r(2): 0.15, P = 0.001). Among 1025 individuals, 392 died after 9 years, 166 from CVD. The HR for CVD/cardiac mortality was not significantly different across tertiles of ox.LDLs or ox.LDL/LDL-C ratio, both in the whole sample and in individuals with prevalent CVD. We conclude that in an elderly population LDL-C, triglycerides, and HDL-C are the most important determinants of ox.LDLs levels, indirectly suggesting an association between small dense LDLs and LDLs oxidation. No association emerged between higher ox.LDLs levels and 9 years CVD/cardiac mortality, suggesting that in advanced age the prognostic information added by ox.LDLs on CVD/cardiac mortality might be negligible.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23141584      PMCID: PMC3529836          DOI: 10.1016/j.atherosclerosis.2012.10.028

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  37 in total

Review 1.  Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.

Authors:  Scott M Grundy; H Bryan Brewer; James I Cleeman; Sidney C Smith; Claude Lenfant
Journal:  Circulation       Date:  2004-01-27       Impact factor: 29.690

2.  Circulating oxidized low-density lipoprotein is an independent predictor for cardiac event in patients with coronary artery disease.

Authors:  Kazunori Shimada; Hiroshi Mokuno; Eriko Matsunaga; Tetsuro Miyazaki; Katsuhiko Sumiyoshi; Katsumi Miyauchi; Hiroyuki Daida
Journal:  Atherosclerosis       Date:  2004-06       Impact factor: 5.162

Review 3.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

Review 4.  Antiinflammatory properties of HDL.

Authors:  Philip J Barter; Stephen Nicholls; Kerry-Anne Rye; G M Anantharamaiah; Mohamad Navab; Alan M Fogelman
Journal:  Circ Res       Date:  2004-10-15       Impact factor: 17.367

5.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

Authors:  M A Austin; M C King; K M Vranizan; R M Krauss
Journal:  Circulation       Date:  1990-08       Impact factor: 29.690

6.  Assessment of LDL particle size by triglyceride/HDL-cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia.

Authors:  Chizuko Maruyama; Kayoko Imamura; Tamio Teramoto
Journal:  J Atheroscler Thromb       Date:  2003       Impact factor: 4.928

7.  beta-Carotene inhibits the oxidative modification of low-density lipoprotein.

Authors:  I Jialal; E P Norkus; L Cristol; S M Grundy
Journal:  Biochim Biophys Acta       Date:  1991-10-15

8.  Autoantibody against oxidised LDL and progression of carotid atherosclerosis.

Authors:  J T Salonen; S Ylä-Herttuala; R Yamamoto; S Butler; H Korpela; R Salonen; K Nyyssönen; W Palinski; J L Witztum
Journal:  Lancet       Date:  1992-04-11       Impact factor: 79.321

9.  The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort.

Authors:  Paul Holvoet; Stephen B Kritchevsky; Russell P Tracy; Ann Mertens; Susan M Rubin; Javed Butler; Bret Goodpaster; Tamara B Harris
Journal:  Diabetes       Date:  2004-04       Impact factor: 9.461

10.  Treating high blood cholesterol in the older patient.

Authors:  D J Gordon; B M Rifkind
Journal:  Am J Cardiol       Date:  1989-05-02       Impact factor: 2.778

View more
  9 in total

1.  Changes in LDL Oxidative Status and Oxidative and Inflammatory Gene Expression after Red Wine Intake in Healthy People: A Randomized Trial.

Authors:  Laura Di Renzo; Luigi Tonino Marsella; Alberto Carraro; Roberto Valente; Paola Gualtieri; Santo Gratteri; Diego Tomasi; Federica Gaiotti; Antonino De Lorenzo
Journal:  Mediators Inflamm       Date:  2015-05-25       Impact factor: 4.711

2.  Relationship between oxidized low-density lipoprotein antibodies and obesity in different glycemic situations.

Authors:  Abdullatif Taha Babakr; Osman Mohamed Elsheikh; Abdullah A Almarzouki; Adel Mohamed Assiri; Badr Eldin Elsonni Abdalla; Hani Yousif Zaki; Samir H Fatani; EssamEldin Mohamed NourEldin
Journal:  Diabetes Metab Syndr Obes       Date:  2014-10-24       Impact factor: 3.168

3.  Oxidized Low Density Lipoprotein and High Sensitive C-Reactive Protein in Non-Diabetic, Pre-Diabetic and Diabetic Patients in the Acute Phase of the First Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.

Authors:  Danijela Trifunović; Sanja Stanković; Jelena Marinković; Marko Banović; Nina Đukanović; Olga Vasović; Bosiljka Vujisić-Tešić; Milan Petrović; Jelena Stepanović; Ana Đorđević-Dikić; Branko Beleslin; Ivana Nedeljković; Milorad Tešić; Miodrag Ostojić
Journal:  J Med Biochem       Date:  2015-03-03       Impact factor: 3.402

Review 4.  Oxidative stress, aging, and diseases.

Authors:  Ilaria Liguori; Gennaro Russo; Francesco Curcio; Giulia Bulli; Luisa Aran; David Della-Morte; Gaetano Gargiulo; Gianluca Testa; Francesco Cacciatore; Domenico Bonaduce; Pasquale Abete
Journal:  Clin Interv Aging       Date:  2018-04-26       Impact factor: 4.458

5.  Effect of a barley-vegetable soup on plasma carotenoids and biomarkers of cardiovascular disease.

Authors:  Tiziana Bacchetti; Domenico Tullii; Simona Masciangelo; Rosaria Gesuita; Edlira Skrami; Francesca Brugè; Sonia Silvestri; Patrick Orlando; Luca Tiano; Gianna Ferretti
Journal:  J Clin Biochem Nutr       Date:  2015-06-05       Impact factor: 3.114

6.  Oxidized low density lipoprotein and total antioxidant capacity in type-2 diabetic and impaired glucose tolerance Saudi men.

Authors:  Essam Eldin Mohamed Nour Eldin; Abdullah Almarzouki; Adel Mohamed Assiri; Osman Mohammed Elsheikh; Badreldin Elsonni Abdalla Mohamed; Abdullatif Taha Babakr
Journal:  Diabetol Metab Syndr       Date:  2014-08-30       Impact factor: 3.320

Review 7.  Association between circulating oxidized low-density lipoprotein and atherosclerotic cardiovascular disease.

Authors:  Shen Gao; Jing Liu
Journal:  Chronic Dis Transl Med       Date:  2017-05-25

8.  The relationship between oxidized low-density lipoprotein and related ratio and acute cerebral infarction.

Authors:  Zhen Yan; Baosheng Fu; Dan He; Yudi Zhang; Juanjuan Liu; Xiangjian Zhang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

Review 9.  Exploring New Kingdoms: The Role of Extracellular Vesicles in Oxi-Inflamm-Aging Related to Cardiorenal Syndrome.

Authors:  Cristina Mas-Bargues; Matilde Alique; María Teresa Barrús-Ortiz; Consuelo Borrás; Raquel Rodrigues-Díez
Journal:  Antioxidants (Basel)       Date:  2021-12-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.